Please let us know why you would like to connect with the company
Business Proposal
Interested to Invest
Strategic Partnership
Would like to work with them
Congratulate them
Anything Else
Please share a crisp & clear message on why you are looking to connect.
To : Founder at AarogyaAI
AarogyaAI Innovations Pvt. Ltd. diagnoses drug-resistant TB (DR-TB) using artificial intelligence in a few hours so that the patient can be prescribed effective drug treatments for treatment without delay while also ensuring that it remains an affordable and available to people from remote places.
See more
Basic Information
Delhi based AarogyaAI Innovations Pvt. Ltd. diagnoses drug-resistant TB (DR-TB) using artificial intelligence in a few hours. The company enables quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment without delay. The test can also precisely mention the drugs and conclude if they would work on the patient. The aim is to make this test available at the most remote place at affordable prices. They have already procured the data and built partnerships with Genotypic and CCAMP in Bengaluru, Lifeline Laboratories, Indian Spinal injuries Centre and Sir Gangaram Hospital in Delhi; and Foundation of Medical Research, IQVIA in Mumbai. Aarogya.AI will also be developing tests for other anti-microbial diseases such as urinary tract infection and cholera in the next phase of growth for the company.
See more
Tech30 Pitch
Video not supported in your device
Timeline
2019
true
Apr | Accelerator / Incubator Program
Pitched to the investment committee of Entrepreneur First- a UK-based incubator.
May | Company Incorporation
AarogyaAI Innovations Private Limited was incorporated.
Jun | Advisor Onboarded
Dr. Soumya Swaminathan, Chief Scientist at World Health Organisation, and a tuberculosis physician, was onboarded as an advisor.
Oct | Awards
Best pitch at Shakti Challenge for Women 2019
2020
Mar | Awards
BIRAC-TiE WInER Award for Women in Entrepreneurial Research
See More
Revenue Streams
Target Market
B2B
AarogyaAI is targeting diagnostic labs and hospitals, to offer our services to its patients. B2B2C model.
Client Segment
:
HealthTech / MedTech / Healthcare
Target Companies
:
Startup
Funding
Total Funding
$250.0k
Investors
:
1.
Entrepreneur First
Detail Round Breakdown
Round 1
Recently Added Startups
Recently Added Startups
Sign up to YourStory
By signing up for YourStory, you agree to the Terms of Service
and Privacy Policy of the platform